IL2 and lymphoma: On the other hand, patients with lymphoma exhibited a loss of functional EBV-specific CD4+ T cells, as demonstrated by TNF-α+ (p = 0.008); IFN-γ+ (p = 0.025); and IL-2+ (p = 0.009) counts.